MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-06-0010438
Ridley Life Science Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹29.98 Cr
▼ 28% YoY
Net profit · FY 2024
₹9.59 Lakh
Net margin 0.3%
EBITDA · FY 2024
₹2.84 Cr
EBITDA margin 9.5%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹8.28 Cr
Issued & subscribed
Open charges
₹24.44 Cr
Satisfied ₹2.98 Cr
Company age
22 yrs
Est. 2004
Employees · EPFO
30
Provident fund records
About Ridley Life Science Private Limited
Data last updated:
Ridley Life Science Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 September 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2004PTC129295. Its GSTIN is 07AACCT4181A1ZP (Delhi). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹8.28 Cr. It was formerly known as Terex Pharmaceuticals Pvt Ltd and Torex Pharmaceuticals Private Limied. It is led by directors including Rakesh Bansal and Rajesh Bansal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at D – 1651 Dsidc Industrial Complex Narela, Delhi, India – 110040.
As per the financials filed for FY 2024, the company reported a revenue of ₹29.98 Cr, a decline of 28% compared to the previous year. For the same year it recorded a net profit of ₹9.59 Lakh (net margin 0.3%) and EBITDA of ₹2.84 Cr (EBITDA margin 9.5%). Revenue has declined at a compounded annual rate (CAGR) of 34% over three years and 25% over five years.
The company has about 30 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹24.44 Cr and satisfied charges of ₹2.98 Cr on record. Court records list 118 cases involving the company, including 33 filed by the company and 85 filed against it; 48 cases are pending. The company has 13 deals on record (8 secondary share transfers, 3 funding rounds, 2 rights issues), with disclosed funding of ₹3.91 Cr; the latest was in March 2021. Its 4 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 3 smaller; the largest is Spen Formulations Pvt Ltd with revenue of ₹29.98 Cr.
Ridley Life Science Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0010438). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rlspl.com.
Company Details of Ridley Life Science Private Limited
CIN U24232DL2004PTC129295
Registration Number 129295
Incorporation Date 21 September 2004
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-06-0010438
Name History
Ridley Life Science has undergone 2 name changes throughout its history. The company was previously known as Terex Pharmaceuticals Pvt Ltd, and Torex Pharmaceuticals Private Limied. The current legal name is Ridley Life Science Private Limited.
| Company Name | Status |
|---|---|
| Ridley Life Science Private Limited | Current |
| Terex Pharmaceuticals Pvt Ltd | Previous |
| Torex Pharmaceuticals Private Limied | Previous |
Recognitions & Rankings of Ridley Life Science
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressD – 1651 Dsidc Industrial Complex Narela, Delhi, India – 110040
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Ridley Life Science Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity
The main business activity of Ridley Life Science is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Ridley Life Science Private Limited
FY 2024 filings availableRidley Life Science Private Limited reported revenue of ₹29.98 Cr (down 28% YoY) for FY 2024.
Revenue · FY 2024
₹29.98 Cr ▼ 28%
Net profit · FY 2024
₹9.59 Lakh margin 0.3%
EBITDA · FY 2024
₹2.84 Cr margin 9.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 28%
3 years · compounded
▼ 34%
5 years · compounded
▼ 25%
EBITDA CAGR growth
1 year
▲ 15%
3 years · compounded
▼ 23%
5 years · compounded
▼ 16%
Revenue has declined at a compounded annual rate (CAGR) of 25% over five years, including a 28% fall in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2019-20 to FY 2022-23in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | ₹29.98 Cr | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹2.84 Cr | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹9.59 Lakh | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2023-24 | FY 2019-20 to FY 2022-23in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 9.5% | |
| Net Profit Margin | 0.3% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2019-20 to FY 2022-23, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ridley Life Science are in the company report.
: available in the company report
Board of Directors of Ridley Life Science Private Limited
Ridley Life Science has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakesh Bansal Also directs: Macred Enterprises LLP, Accrenia Enterprises LLP | Director | 21 Sep 2004 | 22 Years 1 Months | Current |
| Rajesh Bansal Also directs: Aisen Lifesciences LLP, Meczen Biogenics LLP | Director | 21 Sep 2004 | 22 Years 1 Months | Current |
| Ram Kumar Gautam Also directs: Mackbien Pharma LLP | Director | 15 Nov 2019 | 6 Years 11 Months | Current |
Peer Comparison
Ridley Life Science Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Spen Formulations Pvt Ltd | ₹29.98 Cr (FY 2025) | •••• | •••• | -8.0% | •••• | Himachal Pradesh, India |
| Ridley Life Science Private Limited this company | ₹29.98 Cr (FY 2024) | •••• | •••• | -28.0% | •••• | Delhi, India |
| Impact Healthcare Private Limited | ₹29.98 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | New Delhi, Delhi, India |
| Prashanti Formulations Limited | ₹29.89 Cr (FY 2025) | •••• | •••• | -26.0% | •••• | Hoshiarpur, Punjab, India |
| Apex Formulations Private Limited | ₹29.85 Cr (FY 2025) | •••• | •••• | 25.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the companies nearest to Ridley Life Science by revenue, above and below it, in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details
Ridley Life Science Private Limited is audited by Sharma Sheashav & Associates for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Sharma Sheashav & Associates | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Open charges
₹24.44 Cr
Satisfied charges
₹2.98 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Aug 2020 | Axis Bank Limited | ₹16.94 Cr | Open |
| 15 Jun 2012 | Bank of Baroda | ₹7.5 Cr | Open |
| 19 May 2020 | Others | ₹55 Lakh | Satisfied |
| 11 Apr 2017 | Hdfc Bank Limited | ₹1.85 Cr | Satisfied |
| 31 Dec 2013 | Intec Capital Limited | ₹57.75 Lakh | Satisfied |
Total charge records: 5 View all charges
Deals & Funding
Ridley Life Science Private Limited has 13 deals on record (8 secondary share transfers, 3 funding rounds, 2 rights issues), with disclosed funding of ₹3.91 Cr; the latest was in March 2021.
Total deals
13
Secondary share transfers
8
Funding rounds
3
Rights issues
2
Disclosed funding
₹3.91 Cr
Deals on record (5 of 13)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Rights issue | ₹1 Cr | Investors: 2 individuals |
| Dec 2019 | Rights issue | ₹4 Cr | Investors: 2 individuals |
| Sep 2019 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Oct 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Zippy Consultants Private Limited |
| Mar 2012 | Funding round | ₹1.46 Cr | Investors: M G Pharma, 3 individuals |
: available in the company report
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases
Ridley Life Science Private Limited has 118 court cases on record: 33 filed by Ridley Life Science, 85 filed against it. 48 cases are pending and 70 are disposed.
Total cases
118
Filed by the company
33
Filed against the company
85
Pending
48
Disposed
70
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 73 | 66 | 35 |
| High courts | 36 | 11 | 7 |
| NCLAT | 7 | 7 | 6 |
| Supreme Court | 2 | 1 | 0 |
Cases on record (5 of 118)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Commercial matter | Filed against the company by M/S. Vinworld Healthcare Private Limited Through His Director Mr. Arpit Kishandas Agarwal | Pending |
| District court, North West, Delhi | Criminal case | Filed against the company by Axis Bank Limited | Pending |
| District court, North, Delhi | Court case (CS (COMM.)) | Filed against the company by Agi Greenpac Limited Formerly Known As Hsil Limited and 1 other | Pending |
| District court, North, Delhi | Civil suit | Filed against the company by Fishfa Biogenics Ltd | Pending |
| High Court of Delhi | Writ petition | Filed by the company against Axis Bank Limited & Anr. | Pending |
: available in the company report
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance
Ridley Life Science Private Limited has a workforce of 30 employees as of Mar 19, 2025.
Employee count
30
Active EPFO establishments
1
Employee growth
-16.67%
: available in the company report
Recent Activity
Ridley Life Science Private Limited has 4 board changes on record since 2004: 3 appointments and 1 cessation. The latest: Ram Kumar Gautam ceased to be Additional Director on 31 Dec 2020.
AGM
Ridley Life Science Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Ridley Life Science Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Axis Bank Limited of Rs. 16.94 Cr registered on 28 Aug 2020 with Charge ID 100364628 was modified on 01 Nov 2021.
Charges
A charge registered on 19 May 2020 via Charge ID 100341915 with Others was fully satisfied on 14 Jan 2021.
Ceased
Ram Kumar Gautam ceased to be Additional Director.
Charges
A charge registered on 11 Apr 2017 via Charge ID 100102527 with Hdfc Bank Limited was fully satisfied on 02 Dec 2020.
Charges
A charge with Axis Bank Limited amounted to Rs. 16.94 Cr with Charge ID 100364628 was registered on 28 Aug 2020.
Charges
A charge with Others amounted to Rs. 0.55 Cr with Charge ID 100341915 was registered on 19 May 2020.
Appointed
Ram Kumar Gautam was appointed as Director.
Charges
A charge registered on 31 Dec 2013 via Charge ID 10470983 with Intec Capital Limited was fully satisfied on 07 Jun 2017.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.85 Cr with Charge ID 100102527 was registered on 11 Apr 2017.
Charges
A charge with Bank Of Baroda of Rs. 7.50 Cr registered on 15 Jun 2012 with Charge ID 10359713 was modified on 21 Oct 2015.
5 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Ridley Life Science has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCT4181A1ZP | Delhi | Active | 01 Jul 2017 |
| 06AACCT4181A1ZR | Haryana | Active | 13 Nov 2018 |
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Ridley Life Science is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 September 2004 (22+ years old) and is registered under CIN U24232DL2004PTC129295.
Ridley Life Science has 3 current directors:
- Rakesh Bansal - Director
- Rajesh Bansal - Director
- Ram Kumar Gautam - Director
The latest financial statements of Ridley Life Science on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Ridley Life Science is 07AACCT4181A1ZP, registered in Delhi. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 06AACCT4181A1ZR (Haryana).
The CIN (Corporate Identification Number) of Ridley Life Science is U24232DL2004PTC129295. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ridley Life Science has 118 court cases on record: 33 filed by the company and 85 filed against it. 48 are pending. Most are in the district courts.
Ridley Life Science was incorporated on 21 September 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.
Ridley Life Science has 13 deals on record (8 secondary share transfers, 3 funding rounds, 2 rights issues), with disclosed funding of ₹3.91 Cr; the latest was in March 2021.
The peers of Ridley Life Science by revenue are Spen Formulations Pvt Ltd, Impact Healthcare Private Limited, Prashanti Formulations Limited, Apex Formulations Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ram Kumar Gautam ceased to be Additional Director on 31 Dec 2020. Ram Kumar Gautam was appointed as Director on 15 Nov 2019. Rajesh Bansal was appointed as Director on 21 Sep 2004. Ridley Life Science has 4 board changes on record in total.
Yes, Ridley Life Science is registered as a small enterprise under Udyam registration (number: UDYAM-DL-06-0010438).